Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

CTRV

Contravir Pharmaceuticals Inc (CTRV)

Contravir Pharmaceuticals (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTRV
日付受信時刻ニュースソース見出しコード企業名
2019/11/0820 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/11/0802 : 56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/2405 : 30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/2205 : 26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/1705 : 54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/1100 : 33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/0905 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/10/0405 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/09/0500 : 47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/09/0405 : 40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/08/1506 : 30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/08/1422 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/08/0802 : 12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/08/0102 : 42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/3105 : 50Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/3005 : 15GlobeNewswire Inc.Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2605 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2321 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/07/2303 : 00GlobeNewswire Inc.ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/06/2821 : 43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/06/2722 : 54Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/06/2721 : 00GlobeNewswire Inc.ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/06/2105 : 30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTRVContravir Pharmaceuticals (MM)
2019/06/2105 : 30GlobeNewswire Inc.ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASHNASDAQ:CTRVContravir Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CTRV